4TEEN4 Pharmaceuticals: Funding, Investors & Team (Sep 2026)
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment of Circulatory Shock.
4TEEN4 Pharmaceuticals has raised $35.9M across 1 funding round on record, the most recent a Series C of $35.9M announced in Nov 2025.
That round is above the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
4TEEN4 Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Nov 2025.
4TEEN4 Pharmaceuticals Funding Rounds
4TEEN4 Pharmaceuticals Founders and Leadership Team
Contact details for the 4TEEN4 Pharmaceuticals team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →4TEEN4 Pharmaceuticals Funding Compared to Other Biotechnology Startups
4TEEN4 Pharmaceuticals' latest round of $35.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 4TEEN4 Pharmaceuticals in Biotechnology and Hennigsdorf
Companies Similar to 4TEEN4 Pharmaceuticals
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary…
Brise Pharma operates in the scientific research and technical service industry.
Vybio is a high-tech enterprise focusing on innovative drug research and development.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates…
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
4TEEN4 Pharmaceuticals Funding FAQs
What does 4TEEN4 Pharmaceuticals do?
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment of Circulatory Shock.
How much funding has 4TEEN4 Pharmaceuticals raised?
4TEEN4 Pharmaceuticals has raised $35.9M across 1 round on record. The most recent is a Series C of $35.9M announced in Nov 2025.
When did 4TEEN4 Pharmaceuticals last raise funding?
4TEEN4 Pharmaceuticals' most recent funding round on record is a Series C of $35.9M, announced in Nov 2025.
Where is 4TEEN4 Pharmaceuticals headquartered?
4TEEN4 Pharmaceuticals is based in Hennigsdorf, Germany.
How many employees does 4TEEN4 Pharmaceuticals have?
4TEEN4 Pharmaceuticals is in the 11-50 employee band.
How does 4TEEN4 Pharmaceuticals' funding compare to other Biotechnology startups?
4TEEN4 Pharmaceuticals' latest round of $35.9M is above the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's 4TEEN4 Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 4TEEN4 Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.